QCTR Ltd

QCTR is the ONLY CRO to focus exclusively on clinical trials in CNS.
With its subjective assessments and often subjective diagnosis, along with lack of biomarkers and high placebo response, CNS offers unique challenges. 
QCTR have over 15 years of experience in CNS covering diseases as diverse as Alzheimer's, TBI, stroke and schizophrenia, and orphan diseases such as Huntington's and FTD.


With a worldwide network of experienced clinicans working in neurology and psychiatry, and experienced staff knowledgable in the therapeutic field, we can plan and execute cost effective clinical trials to meet your company's specific requirements.

Website:
www.qctr.co.uk
Company type
Dr Audrey Jamieson
Business Development Manager 

Quay Pharma

Quay Pharma is one of the world’s leading Contract Development and Manufacturing Organisations, or CDMOs. Based in the UK, we provide specialist services to the pharmaceutical and biotech industries built on our unique expertise in drug formulation development, analytical services and contract manufacturing.

Quay provides formulation, analytical development and clinical trials manufacturing for companies world-wide. Applying strong project management, products are quickly and cost effectively taken from pre-clinical through phase II trials. Having deep knowledge in solid dosage form development, particularly improving bioavailability of NCEs, has resulted in many clients successfully licensing products on to large pharmaceutical companies.

Company type
Mr Michael Kruidenier
Business Development Manager 
Ms Mairaedh Pedersen
Chief Executive Officer